A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
Public ClinicalTrials.gov record NCT07787169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Master Protocol for Phase 1 Clinical Trials of Multiple Amyloid-Targeting Therapies for the Treatment of Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this Master Protocol is to support multiple studies looking at safety and tolerability of different drugs in healthy participants and participants with Alzheimer's disease, and if they remove clumps of protein (amyloid plaque) in the brain in participants with Alzheimer's Disease. Participants will enroll into either A1D-MC-AT01 (NCT07787182) or A1D-MC-AT02 (upcoming).
Study identification
- NCT ID
- NCT07787169
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 179 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2026 (Actual)
- Primary completion
- Jul 2028 (Estimated)
- Completion
- Jul 2028 (Estimated)
- Last update posted
- Oct 8, 2026
2026 – 2028
United States locations
- U.S. sites
- 13
- U.S. states
- 4
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CenExel ACT | Anaheim | California | 92801 | Not yet recruiting |
| Irvine Clinical Research | Irvine | California | 92614 | Not yet recruiting |
| Collaborative Neuroscience Network - CNS | Los Alamitos | California | 90720 | Not yet recruiting |
| Fortrea Clinical Research Unit | Daytona Beach | Florida | 32117 | Recruiting |
| K2 Medical Research - The Villages | Lady Lake | Florida | 32159 | Not yet recruiting |
| K2 Medical Research | Maitland | Florida | 32751 | Not yet recruiting |
| Charter Research | Orlando | Florida | 32803 | Not yet recruiting |
| Progressive Medical Research | Port Orange | Florida | 32127 | Not yet recruiting |
| Alzheimer's Research and Treatment Center | Stuart | Florida | 34996 | Not yet recruiting |
| K2 Medical Research - Tampa | Tampa | Florida | 33634 | Not yet recruiting |
| Charter Research | The Villages | Florida | 32162-2698 | Not yet recruiting |
| Accel Research Sites - NeuroStudies Clinical Research Unit | Decatur | Georgia | 30030 | Not yet recruiting |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07787169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07787169 live on ClinicalTrials.gov.